Speaker :

Dr. Joydeep Ghosh, Medical Oncologist, Kolkata

nextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in   combination with tamoxifen in patients with HR+, HER2- metastatic breast cancer

Author: Hamilton EP 

 Citation: ESMO Virtual Congress 2020 : abstract 2730

PALOMA-3 Exploratory Analysis: Who Benefits Most From Palbociclib? (Predictors of  efficacy in patients with hormone receptor-positive/human epidermal growth factor  receptor 2-negative advanced breast cancer: Subgroup analyses of PALOMA-3)

Author: Rugo H

 Citation: European Breast Conference 2020, Abstract 9